false
0001540684
0001540684
2025-12-12
2025-12-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 12, 2025
ATLAS
LITHIUM CORPORATION
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-41552 |
|
39-2078861 |
(State
or Other Jurisdiction
of
Incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
Number) |
Rua
Antonio de Albuquerque, 156 - 17th Floor
Belo
Horizonte, Minas Gerais, Brazil, 30.112-010
(Address
of principal executive offices, including zip code)
(833)
661-7900
(Registrant’s
telephone number, including area code)
Not
applicable
(Former
address if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of Each Class |
|
Trading
Symbol(s) |
|
Name
of Each Exchange on Which Registered |
| Common
Stock, $0.001 par value |
|
ATLX |
|
The
Nasdaq Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
As previously disclosed, Atlas Lithium Corporation
(the “Company”) entered into that certain At The Market Offering Agreement, dated November 22, 2024 (the “Agreement”)
with H.C. Wainwright & Co., LLC, as sales agent (“Wainwright”) with respect to an at the market offering program
(the “ATM Program”), under which the Company may, from time to time in its sole discretion, issue and sell through
Wainwright, acting as agent, shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”).
On December 12, 2025, the Company filed a prospectus
supplement (the “Prospectus Supplement”) with the Securities and Exchange Commission (the “SEC”)
pursuant to Rule 424(b) promulgated under the Securities Act of 1933, as amended, under the Company’s existing shelf registration
statement on Form S-3 (File No. 333-289905) filed by the Company with the SEC on August 22, 2025, which became effective on September
3, 2025 (the “Registration Statement”), including the base prospectus contained therein, dated August 22, 2025, forming part
of the Registration Statement. The Prospectus Supplement relates to the offer and sale from time to time by the Company, at
its sole discretion, through Wainwright as part of the ATM Program, additional shares of Common Stock having an aggregate offering price
of up to $40,000,000 (the “Shares”).
The legal opinion of Brownstein Hyatt Farber Schreck,
LLP as to the legality of the Shares under Nevada law is being filed as Exhibit 5.1 to this Current Report on Form 8-K.
This Current Report on Form 8-K shall not constitute
an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation or
sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such jurisdiction.
Item 9.01. Financial Statements and Exhibits.
|
Exhibit
No. |
|
Description |
| 5.1 |
|
Opinion of Brownstein Hyatt Farber Schreck, LLP |
| 23.1 |
|
Consent of Brownstein Hyatt Farber Schreck, LLP (included in Exhibit 5.1) |
| 104 |
|
Cover Page Interactive Data File (embedded with the Inline XRBL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
| |
ATLAS
LITHIUM CORPORATION |
| |
|
|
| Dated:
December 12, 2025 |
By: |
/s/
Marc Fogassa |
| |
Name: |
Marc
Fogassa |
| |
Title: |
Chief
Executive Officer |